AJMAL R BHAT

Dr. AJMAL R BHAT

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Bioorganic Chemistry
Verified
Journal Article
Closed access
ABAJMAL R BHAT
AJMAL R BHAT
RDRajendra S. Dongre
Rajendra S. Dongre
FAFaisal A. Almalki
Faisal A. Almalki
MBMalika Berredjem
Malika Berredjem
MAMohamed Aissaoui
Mohamed Aissaoui
MAMohammad S. Akhter
Mohammad S. Akhter

4 July 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SHSangar Ali Hassan
Sangar Ali Hassan
DADara Aziz
Dara Aziz
MAMedia Noori Abdullah
Media Noori Abdullah
ABAJMAL R BHAT
AJMAL R BHAT
RDRajendra S. Dongre
Rajendra S. Dongre
JJJoazaizulfazli Jamalis
Joazaizulfazli Jamalis
In this work, Schiff bases and Thiazolidin-4-ones, were synthesized using Sonication and Microwave techniques, respectively. The Schiff base derivatives (3a-b) were synthesized via the reaction of Sulfathiazole (1) with benzaldehyde derivatives (2a-b), followed by the synthesis of 4-thiazoledinone (4a-b) derivatives by cyclizing the synthesized Schiff bases through thioglycholic acid. All the synthesized compounds were characterized by spectroscopic techniques such as FT IR, NMR and HRMS. The synthesized compounds were tested for their in vitro antimicrobial and antioxidant and in vivo cytotoxicity and hemolysis ability. The synthesized compounds displayed better antimicrobial and antioxidant activity and low toxicity in comparison to reference drugs and negative controls, respectively. The hemolysis test revealed the compounds exhibit lower hemolytic effects and hemolytic values are comparatively low and the safety of compounds is in comparison with standard drugs. Theoretical calculations were carried out by using the molecular operating environment (MOE) and Gaussian computing software and observations were in good agreement with the in vitro and in vivo biological activities. Petra/Osiris/Molinspiration (POM) results indicate the presence of three combined antibacterial, antiviral and antitumor pharmacophore sites. The molecular docking revealed the significant binding affinities and non-bonding interactions between the compounds and Erwinia Chrysanthemi (PDB ID: 1SHK). The molecular dynamics simulation under in silico physiological conditions revealed a stable conformation and binding pattern in a stimulating environment. HighlightsNew series of Thaiazolidin-4-one derivatives have been synthesized.Sonication and microwave techniques are used.Antimicrobial, Antioxidant, cytotoxicity, and hemolysis activities were observed for all synthesized compounds.Molecular Docking and DFT/POM analyses have been predicted.Communicated by Ramaswamy H. Sarma.

30 June 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
SHSangar Ali Hassan
Sangar Ali Hassan
DADara Muhammed Aziz
Dara Muhammed Aziz
MAMedia Noori Abdullah
Media Noori Abdullah
ABAJMAL R BHAT
AJMAL R BHAT
RDRajendra Sukhadeorao Dongre
Rajendra Sukhadeorao Dongre
JJJoazaizulfazli Jamalis
Joazaizulfazli Jamalis

1 November 2015 in Journal of Advanced Research
Verified
Journal Article
Open access
ABAJMAL R BHAT
AJMAL R BHAT
ASAabid H. Shalla
Aabid H. Shalla
RDRajendra Sukhadeorao Dongre
Rajendra Sukhadeorao Dongre
An efficiently simple protocol for the synthesis of methyl 7 amino-4-oxo-5-phenyl-2-thioxo-2, 3, 4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carboxylates via one-pot three component condensation pathway is established via microwave irradiation using varied benzaldehyde derivatives, methylcyanoacetate and thio-barbituric acid in water as a green solvent. A variety of functionalized substrates were found to react under this methodology due to its easy operability and offers several advantages like, high yields (78-94%), short reaction time (3-6 min), safety and environment friendly without used any catalyst. The synthesized compounds (4a-4k) showed comparatively good in vitro antimicrobial and antifungal activities against different strains. The Compounds 4a, 4b, 4c, 4d 4e and 4f showed maximum antimicrobial activity against Staphylococcus aureus, Bacillus cereus (gram-positive bacteria), Escherichia coli, Klebshiella pneumonia, Pseudomonas aeruginosa (gram-negative bacteria). The synthesized compound 4f showed maximum antifungal activity against Aspergillus Niger and Penicillium chrysogenum strains. Streptomycin is used as standard for bacterial studies and Mycostatin as standards for fungal studies. Structure of all newly synthesized products was characterized on the basis of IR, (1)H NMR, (13)C NMR and mass spectral analysis.

1 January 2016 in Journal of Taibah University for Science
Verified
Journal Article
Open access
ABAJMAL R BHAT
AJMAL R BHAT
ASAabid H. Shalla
Aabid H. Shalla
RDRajendra S. Dongre
Rajendra S. Dongre
Annulated pyrano[2,3-d]pyrimidine derivatives were synthesized via one-pot, three-component condensation reactions of various aromatic aldehydes, malononitrile and barbituric acid in aqueous ethanol using dibutylamine (DBA) as catalyst. The potential application of DBA in organic synthesis is increasing rapidly due to its reaction simplicity, minimal reaction time, high yields of the desired products (83–94%) and low cost chemicals. All of the synthesized pyrano[2,3-d]pyrimidine derivatives were characterized by IR, 1H NMR, 13C NMR and mass spectra

13 August 2025 in In Silico Research in Biomedicine
Verified
Journal Article
Open access
ABAJMAL R BHAT
AJMAL R BHAT
SASumeer Ahmed
Sumeer Ahmed